Simeonidis Simos 4
4 · Regulus Therapeutics Inc. · Filed Jun 19, 2020
Insider Transaction Report
Form 4
Simeonidis Simos
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-17+23,250→ 23,250 totalExercise: $0.88Exp: 2030-06-16→ Common Stock (23,250 underlying)
Footnotes (1)
- [F1]Pursuant to the Company's Non Employee Director's Compensation policy, the options are automatically granted on the date of the Company's Annual Meeting of Stockholders and will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the Company's next annual stockholder meeting, whichever occurs first, subject to the Reporting Person's continuous service.